ILK is overexpressed in ovarian cancer relative to normal ovarian tissue: To identify reliable therapeutic targets for advanced ovarian cancer, high-grade treatment-naïve ovarian cancer specimens, and pair-matched adjacent normal ovarian tissues were obtained from the CHTN (Figure 1). This evidence concerns the gene ILK and ovarian carcinoma.